“…Further, ncAA incorporation into proteins has opened the way to novel antibody drug conjugates (Axup et al, 2012; Zimmerman et al, 2014), modified human therapeutics (Cho et al, 2011), and protein biomaterials (Albayrak and Swartz, 2014), among other applications. With the ability to construct bio-based products beyond the limits of nature, expanding the genetic code has emerged as a major opportunity in synthetic and chemical biology (Des Soye et al, 2015; Hoesl and Budisa, 2012; Liu and Schultz, 2010; Quast et al, 2015). …”